Apellis Pharmaceuticals, Inc. APLS NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

48/100

1/7 Pass

SharesGrow Intrinsic Value

Apellis Pharmaceuticals, Inc. (APLS) has 20 알려진 내부자 및 기관 보유자 기록. 최대 보유자는 Morningside Venture Investments Ltd 12,806,342 주 보유. 기타 주요 보유자에는 Deschatelets Pascal 및 Francois Cedric.

지난 12개월간 내부자는 86 건의 거래를 수행 APLS 주식 — 32 건 매수 (평가액 $19.26M) 및 39 건 매도 (평가액 $10.82M). 내부자 매도가 매수를 초과했습니다.

APLS 내부자 보유 현황

최대 보유자

Morningside Venture Investments Ltd

12,806,342 주

매수 (12개월)

$19.26M 평가액

매도 (12개월)

$10.82M 평가액

12개월 거래 활동

매수 37%

매도 45%

내부자 주요 보유자

#	이름	직책	보유 주식수	최종 신고일	상대적 규모
1	Morningside Venture Investments Ltd	10 Percent Owner	12,806,342	2021-11-18	100%
2	Deschatelets Pascal	Chief Scientific Officer	1,177,222	2026-01-30	9%
3	Francois Cedric	Chief Executive Officer	372,815	2026-03-13	3%
4	Sullivan Timothy Eugene	Chief Financial Officer	152,041	2026-01-30	1%
5	Watson David O.	General Counsel	144,517	2026-01-30	1%
6	Boucher Kelley	Chief People Officer	127,804	2026-01-30	1%
7	Nicholson Nur	Chief Technical Officer	116,338	2026-01-30	1%
8	Delong Mark Jeffrey	Chief Business & Strat Officer	114,591	2026-02-13	1%
9	Meltzer Leslie	Chief Research and Development	107,024	2026-01-30	1%
10	Grossi Federico	Chief Medical Officer	94,884	2023-01-09	1%
11	Baumal Caroline	Chief Medical Officer	86,527	2026-01-23	1%
12	Townsend Adam J.	Chief Commercial Officer	84,050	2025-01-30	1%
13	Lewis Karen	Chief People Officer	70,251	2025-01-30	1%
14	Chopas James George	VP/chief Accounting Officer	65,955	2026-01-30	1%
15	Eisele Jeffrey	Chief Development Officer	55,312	2025-01-30	0%
16	Scheibler Lukas	Chief Research Officer	39,391	2023-12-05	0%
17	Brown Victoria L.	Program Team Lead	23,556	2023-01-24	0%
18	Walbert Keli	Director	14,684	2026-01-05	0%
19	Wheeler Craig A	Director	14,684	2026-01-05	0%
20	Machiels Alec	Director	14,684	2026-01-05	0%

최근 거래 (최근 12개월)

날짜	이름	직책	유형	주식수	주가	금액
2026-03-31	Biogen Inc.	Other: See Footnotes	알 수 없음	-	-	-
2026-03-11	Francois Cedric	Chief Executive Officer	증여 (수령)	64,869	-	-
2026-03-02	Dolsten Mikael	Director	알 수 없음	-	-	-
2026-02-27	Dolsten Mikael	Director	RSU 부여	14,312	-	-
2026-02-11	Delong Mark Jeffrey	Chief Business & Strat Officer	정보 매도	368	$22.15	$8.15K
2026-02-03	Francois Cedric	Chief Executive Officer	옵션 행사 (매도)	8,840	$3.76	$33.24K
2026-01-28	Meltzer Leslie	Chief Research and Development	RSU 부여	45,220	-	-
2026-01-28	Boucher Kelley	Chief People Officer	RSU 부여	30,146	-	-
2026-01-28	Delong Mark Jeffrey	Chief Business & Strat Officer	RSU 부여	36,606	-	-
2026-01-28	Chopas James George	VP/chief Accounting Officer	RSU 부여	16,150	-	-
2026-01-28	Nicholson Nur	Chief Technical Officer	RSU 부여	45,220	-	-
2026-01-28	Sullivan Timothy Eugene	Chief Financial Officer	RSU 부여	58,140	-	-
2026-01-28	Francois Cedric	Chief Executive Officer	RSU 부여	195,952	-	-
2026-01-28	Deschatelets Pascal	Chief Scientific Officer	RSU 부여	25,840	-	-
2026-01-28	Watson David O.	General Counsel	RSU 부여	55,986	-	-
2026-01-22	Baumal Caroline	Chief Medical Officer	정보 매도	2,797	$21.77	$60.88K
2026-01-22	Delong Mark Jeffrey	Chief Business & Strat Officer	정보 매도	3,371	$21.77	$73.37K
2026-01-22	Chopas James George	VP/chief Accounting Officer	정보 매도	2,064	$21.77	$44.92K
2026-01-22	Nicholson Nur	Chief Technical Officer	정보 매도	7,725	$21.77	$168.14K
2026-01-22	Sullivan Timothy Eugene	Chief Financial Officer	정보 매도	10,287	$21.77	$223.9K
2026-01-22	Francois Cedric	Chief Executive Officer	정보 매도	27,192	$21.77	$591.84K
2026-01-22	Deschatelets Pascal	Chief Scientific Officer	정보 매도	5,928	$21.77	$129.03K
2026-01-22	Watson David O.	General Counsel	정보 매도	7,832	$21.77	$170.47K
2026-01-20	Baumal Caroline	Chief Medical Officer	정보 매도	1,882	$19.79	$37.25K
2026-01-20	Delong Mark Jeffrey	Chief Business & Strat Officer	정보 매도	1,334	$19.79	$26.4K